Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Sensation Disorders » Hearing Disorders » Hearing Loss » Hearing Loss, Sensorineural
Description
Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM. MeSH
Hierarchy View
Subtype Terms (4)
Hearing Loss, Noise-Induced
15 drugs (9 approved, 6 experimental)
Presbycusis
2 experimental drugs
Usher Syndromes
4 experimental drugs
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (5)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (15)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
